Ignite Creation Date:
2024-05-06 @ 6:37 PM
Last Modification Date:
2024-10-26 @ 2:51 PM
Study NCT ID:
NCT05722912
Status:
APPROVED_FOR_MARKETING
Last Update Posted:
2023-02-10
First Post:
2022-10-04
Brief Title:
Expanded Access of Ruxolitinib Cream to Treat a Single Patient With cGVHD
Sponsor:
Incyte Corporation
Organization:
Incyte Corporation
Key Dates - Follows AllAPIJSON File Order
Start Date:
None
Start Date Type:
None
Primary Completion Date:
None
Primary Completion Date Type:
None
Completion Date:
None
Completion Date Type:
None
First Submit Date:
2022-10-04
First Submit QC Date:
January 26 2023
Study First Post Date:
2023-02-10
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-01-26
Last Update Post Date:
2023-02-10
Last Update Post Date Type:
ACTUAL